To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Prostate cancer

Cell culture and mouse studies suggest an N-carboxyaniline-based selective androgen receptor degrader (SARD) could help treat castration-resistant prostate

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE